We demonstrated that Empagliflozin significantly improves stroke recovery, and this effect occurs in association with attenuated hyperglycemia, elevated serum FGF-21 levels and normalization in parenchymal pericyte density in the infarct core. The gene discussed is FGF21; the disease is Stroke.